Understand the source comparison
Comparison to standard treatments
Standard COPD treatment involves bronchodilators to open airways, inhaled corticosteroids to reduce inflammation, and oxygen therapy in advanced cases. These treatments help patients breathe more easily but do not reverse disease progression. Lung function con
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Standard COPD treatment involves bronchodilators to open airways, inhaled corticosteroids to reduce inflammation, and oxygen therapy in advanced cases. These treatments help patients breathe more easily but do not reverse disease progression. Lung function continues to decline. Tissue continues to deteriorate.
- The bronchogen research suggests a different paradigm. Rather than managing symptoms while the disease progresses, the peptide appears to promote actual tissue restoration. The distinction matters enormously for long-term outcomes. Managing decline is not the same as reversing it.
- Of course, significant caveats apply. All bronchogen COPD research to date has been conducted in animal models. We do not have human clinical trials establishing equivalent effects in people. The jump from rat lungs to human lungs is substantial, and many promising animal findings fail to translate to clinical practice.